News List
Fapilavir completes clinical research and shows good clinical efficacy
2020-03-23
On March 17th, the State Council's joint prevention and control mechanism held a press conferenc
Migraine relieved within 1 hour, FDA approves new oral medication
2020-03-01
2020.02.27, Biohaven announced that the US FDA has approved the company's CGRP receptor inhibito
Insomnia and schizophrenia innovative treatments approved
2020-02-04
Dayvigo (lembroexant) developed by Eisai is an orexin receptor antagonist. Orexin is a neuropeptide
First oral small molecule CGRP receptor inhibitor approved today for the treatment of migraine
2020-01-10
Recently, the US FDA announced that it has approved the listing of the calcitonin gene-related pepti
Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
2019-12-21
Novartis recently announced topline results from its pivotal global Phase III LUSTER-11and LUSTER-22
Roche T + A immunotherapy research achieves historic breakthrough
2019-12-12
November 22, 2019, Roche announces data from positive studies of the IMbrave 150 phase III clinical
Hansoh pharm's first sorts of new medicine "Flumatinib" will be approved for listing
2019-11-20
Flumatinib is a tyrosine kinase inhibitor and it’s a second-generation TK inhibitor drug against Bcr
FDA approves Lilly Reyvow
2019-10-21
Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmidit
The third anti-tb drug was approved by the FDA
2019-09-24
On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretoman
Holiday Notice of Mid-Autumn Festival
2019-09-11
To all departments and all employees:According to the related provisions on national holidays &